1. Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study. (June 2017) Authors: Fowler, N.; Gopal, A.K.; Schuster, S.J.; Trotman, J.; Hess, G.; Hou, J.; Yacoub, A.; Lill, M.; Martin, P.; Vitolo, U.; Spencer, A.; Radford, J.; Jurczak, W.; Morton, J.; Osmanov, D.; Caballero, D.; Deshpande, S.; Vermeulen, J.; Damle, R.; Schaffer, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN‐LABEL, PHASE II STUDY. (June 2017) Authors: Nastoupil, L.J.; Westin, J.; Fowler, N.; Fanale, M.; Samaniego, F.; Oki, Y.; Obi, C.; Cao, J.; Cheng, X.; Ma, M.; Wang, Z.; Chu, F.; Feng, L.; Zhou, S.; Davis, R.E.; Neelapu, S.S. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PHASE 3 STUDY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB VERSUS PLACEBO IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH TREATMENT‐NAÏVE FOLLICULAR LYMPHOMA (PERSPECTIVE). (June 2017) Authors: Rule, S.; Flinn, I.W.; Fowler, N.; Chen, R.; Kwei, L.; Beaupre, D.M.; Chu, A.D.; Gordon, L.I. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TREATMENT WITH COMBINATION OF LENALIDOMIDE AND RITUXIMAB ACHIEVES DURABLE RESPONSES IN A LONG TERM FOLLOW UP OF PATIENTS WITH INDOLENT NON‐HODGKIN'S LYMPHOMA. (June 2017) Authors: Chaudhry, M.; Nastoupil, L.; Samaniego, F.; Neelapu, S.S.; Hagemeister, F.B.; Fanale, M.A.; Fayad, L.; Westin, J.R.; Oki, Y.; Feng, L.; Fowler, N. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY. (June 2017) Authors: Swinnen, L.J.; Flowers, C.R.; Wang, D.; Reid, E.; Fowler, N.; Cordero, J.; Dunbar, M.; Enschede, S.; Nolan, C.; Petrich, A.M.; Ross, J.; Salem, A.H.; Verdugo, M.; Wong, S.; Zhou, L.; Kozloff, M.; Nastoupil, L.; de Vos, S. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗